Management of Submacular Hemorrhage Using Intravitreal Brolucizumab with Pneumatic Displacement: A Case Series

Somnath Chakraborty1, Jay Umed Sheth2

  • 1Retina Institute of Bengal, Siliguri, India.

Insights

Intravitreal brolucizumab with SF6 gas injection effectively clears large submacular hemorrhage (SMH) from MNV, improving vision. This safe treatment shows sustained results up to six months without side effects.

Area of Science:

  • Ophthalmology
  • Retinal diseases

Background:

  • Submacular hemorrhage (SMH) management requires rapid bleed clearance for visual recovery.
  • Macular neovascularization (MNV) is a common cause of SMH.